サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629875

画像診断機器の世界市場（2025年～2033年）

Global Diagnostic Imaging Devices Market - 2025-2033

出版日
ページ情報
英文 183 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
画像診断機器の世界市場（2025年～2033年）
出版日: 2024年12月30日
発行: DataM Intelligence
ページ情報: 英文 183 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の画像診断機器の市場規模は、2024年に337億米ドルに達し、2033年には526億米ドルに達すると予測され、予測期間2025年～2033年のCAGRは5.1%で成長する見通しです。

画像診断機器は、臨床分析や医療介入のために身体内部の視覚的表現を作成するために使用される医療技術です。これらの機器は、臓器、組織、骨、血管の詳細な画像を提供することで、さまざまな病状の診断、モニタリング、治療に重要な役割を果たしています。医療提供者が病気を特定し、傷害の程度を判断し、病気の進行をモニターし、手術や治療を計画するのに役立つため、現代医療において極めて重要なツールとなっています。

世界の画像診断市場は、医療ニーズの増加、技術の進歩、慢性疾患の蔓延といった様々な要因によって、旺盛な需要が発生しています。例えば、米国疾病予防管理センターによると、米国では推定1億2,900万人が米国保健社会福祉省が定義する少なくとも1つの主要な慢性疾患（心臓病、がん、糖尿病、肥満、高血圧など）を抱えています。米国の主要死因上位10項目のうち5項目が、予防・治療可能な慢性疾患か、あるいはそれに強く関連しています。

市場力学：

促進要因と抑制要因

画像診断機器における技術進歩の高まり

画像診断機器における技術進歩の高まりは、画像診断機器市場の成長を大きく後押ししており、診断精度、効率性、患者の転帰を改善することにより、予測期間中も市場を牽引すると予想されます。これらの技術革新は、画像診断システムの能力を高めるだけでなく、さまざまな臨床分野への応用を拡大しています。

AIと機械学習は、画像解析の速度と精度を向上させることで画像診断に革命をもたらしています。AIツールは画像のパターンを素早く特定し、異常の検出を支援し、医療専門家に意思決定支援を提供することができます。例えば、2024年12月、ロイヤル・フィリップスは、同社が最近導入したCT 5300システムにおけるAIとスマートワークフロー自動化機能による臨床判断支援を発表しました。フィリップスのCTスマートワークフローは、CTワークフローの各ステップで支援するAI対応の「Precise」ソフトウェアソリューションの包括的なスイートを備えており、技師や放射線技師をルーチンワークや時間のかかる作業から解放し、患者に集中する時間を増やすことができます。

3D MRIや3D超音波のような技術は、医療専門家が状態を視覚化し診断する方法を変えました。これらの進歩は、より良い手術計画や病気の進行のモニタリングに不可欠です。例えば、2024年5月、Koelis, SASは、権威ある米国泌尿器科学会年次総会で新機能を発表し、AI強化前立腺MRI機能を独自のTrinityプラットフォームに統合する斬新な能力を実証しました。Koelis Trinityシステムは、泌尿器科医が前立腺がんの3Dターゲット「フュージョン生検」を行うことを可能にします。Trinityは、3D超音波画像と、当社独自の前立腺運動追跡ソフトウェア（OBT Fusion）を搭載した独自のMRI-USフュージョン画像ガイダンスを統合しています。

ハンドヘルド超音波診断機器のようなポータブルな画像診断機器は、特に地方や十分なサービスを受けていない地域における医療へのアクセスを改善しています。これらの機器は、機動性、費用対効果、ポイント・オブ・ケアでの診断能力を提供し、患者が医療施設まで長距離を移動する必要性を低減します。

例えば、ケアストリーム・ヘルス・インドは2023年2月、高出力のCarestream MotionモバイルX線システムを発売しました。このシステムは、一般的なX線撮影検査を実施するための完全な設備を備えています。この新しいポータブル画像システムはコンパクトで、狭い場所でも簡単に操作できます。チューブヘッドや関節アームなどの革新的な機能により、優れた視認性と使いやすさを実現しています。

画像診断機器の高コスト

画像診断機器の高コストは、特に新興国や小規模医療施設において、市場成長の妨げになると予想されます。MRI、CTスキャナ、PETスキャナなどの画像診断機器は、多額の先行投資を必要とするため、コスト高になりやすいです。これは、特に小規模な医療施設や資金力の乏しい開発途上地域の施設にとっては大きな障壁となります。

例えば、ブロック・イメージングによると、CTスキャナーの平均価格はモデルや機能によって大きく異なり、ベーシックモデルの8万米ドルからプレミアムモデルの30万米ドルまでの幅があります。通常、購入者は中級レベルのCTスキャナーに12万米ドル～16万米ドルをかけると予想されます。PET/CTスキャナーの平均的な価格は、エントリーレベルのスキャナーの22万5,000米ドルから、最適化されたスキャニング・システムの47万5,000米ドルにまで及びます。PET/CTスキャナーは、最新で最高のものでは75万米ドルにもなります。

高額な初期費用に加え、これらの画像診断機器には、継続的なメンテナンスと運用にかなりの費用がかかります。機器を効率的に機能させ続けるためには、定期的なメンテナンス、ソフトウェアのアップグレード、修理が必要となります。特に新興経済諸国では、病院や診断センターがすでに厳しい予算に苦しんでいる可能性があります。

目次

第1章 市場イントロダクションと範囲

  • レポートの目的
  • 調査範囲と定義
  • 調査範囲

第2章 エグゼクティブの洞察と重要なポイント

  • 市場のハイライトと戦略的ポイント
  • 主な動向と将来の予測
  • 製品タイプ別のスニペット
  • 画像タイプ別のスニペット
  • 携帯性別のスニペット
  • 用途別のスニペット
  • エンドユーザー別のスニペット
  • 地域別のスニペット

第3章 市場力学

  • 影響要因
    • 促進要因
      • 画像診断機器における技術進歩の高まり
      • 慢性疾患の増加と人口の高齢化
    • 抑制要因
      • 画像診断機器の高コスト
    • 機会
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
    • 新たな先駆者と有望企業
    • 最大の売上を誇るブランドを確立したリーダー
    • 確立された製品を持つ市場リーダー
  • 新興スタートアップ企業と主要イノベーター
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の研究
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析：ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格市場力学

第5章 画像診断機器市場：製品タイプ別

  • PET/CTスキャナ
  • Cアーム
  • MRI機器
  • マンモグラフィーシステム
  • 骨密度計
  • その他

第6章 画像診断機器市場：画像タイプ別

  • X線画像
  • コンピュータ断層撮影（CT）
  • 磁気共鳴画像（MRI）
  • 超音波
  • 核イメージング
  • マンモグラフィー
  • その他

第7章 画像診断機器市場：携帯性別

  • ポータブル機器
  • ハンドヘルド機器
  • 据置型機器

第8章 画像診断機器市場：用途別

  • 心臓病学
  • 腫瘍学
  • 神経学
  • 整形外科
  • 泌尿器科
  • 消化器内科
  • その他

第9章 画像診断機器市場：エンドユーザー別

  • 病院
  • 診断センター
  • 専門クリニック
  • その他

第10章 画像診断機器市場：地域別の市場分析と成長機会

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • 中東・アフリカ

第11章 競合情勢と市場ポジショニング

  • 競合の概要と主要な市場企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併、買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第12章 企業プロファイル

  • Siemens Healthineers AG
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
    • SWOT分析
  • GE HealthCare
  • Koninklijke Philips N.V.
  • CANON MEDICAL SYSTEMS CORPORATION
  • FUJIFILM Holdings Corporation
  • Medtronic plc
  • Hologic, Inc.
  • Abbott Laboratories
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Carestream Health

第13章 前提条件と調査手法

  • データ収集方法
  • データの三角測量
  • 予測技術
  • データの検証とバリデーション

第14章 付録

目次
Product Code: MD8905

The global diagnostic imaging devices market reached US$ 33.7 billion in 2024 and is expected to reach US$ 52.6 billion by 2033, growing at a CAGR of 5.1% during the forecast period 2025-2033.

Diagnostic imaging devices are medical technologies used to create visual representations of the interior of a body for clinical analysis and medical intervention. These devices play a critical role in diagnosing, monitoring, and treating various medical conditions by providing detailed images of organs, tissues, bones, and blood vessels. They are crucial tools in modern medicine, as they help healthcare providers identify diseases, determine the extent of an injury, monitor disease progression, and plan surgeries or treatments.

The global diagnostic imaging market is experiencing robust demand, driven by various factors such as increasing healthcare needs, technological advancements and the growing prevalence of chronic diseases. For instance, according to the Centers for Disease Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease (e.g., heart disease, cancer, diabetes, obesity, hypertension) as defined by the US Department of Health and Human Services. Five of the top 10 leading causes of death in the US are or are strongly associated with preventable and treatable chronic diseases.

Market Dynamics: Drivers & Restraints

Rising technological advancements in diagnostic imaging devices

Rising technological advancements in diagnostic imaging devices are significantly driving the growth of the diagnostic imaging devices market and are expected to drive the market over the forecast period by improving diagnostic accuracy, efficiency and patient outcomes. These innovations not only enhance the capabilities of imaging systems but also expand their applications across various clinical disciplines.

AI and machine learning are revolutionizing diagnostic imaging by improving the speed and accuracy of image analysis. AI tools can quickly identify patterns in images, assist in detecting abnormalities and provide decision support to healthcare professionals. For instance, in December 2024, Royal Philips announced clinical decision-support with AI and smart workflow automation capabilities in the company's recently introduced CT 5300 system. Philips' CT Smart Workflow features a comprehensive suite of AI-enabled 'Precise' software solutions that assist at every step of the CT workflow, freeing technicians and radiologists from routine, time-consuming tasks and allowing them more time to focus on their patients.

Technologies like 3D MRI and 3D ultrasound have transformed how healthcare professionals visualize and diagnose conditions. These advancements are crucial for better surgical planning and monitoring of disease progression. For instance, in May 2024, Koelis, SAS released new features at the prestigious American Urological Association Annual Meeting to demonstrate its novel capacity to integrate AI-enhanced prostate MRI features into its exclusive Trinity platform. The Koelis Trinity system enables urologists to perform 3D targeted "fusion biopsy" in prostate cancer. Trinity integrates 3D ultrasound imaging with proprietary MRI-US fusion image guidance that features the Company's unique prostate motion tracking software (OBT Fusion).

Portable diagnostic imaging devices, such as handheld ultrasound machines, are improving access to care, especially in rural or underserved areas. These devices offer mobility, cost-effectiveness, and the ability to perform diagnostics at the point of care, reducing the need for patients to travel long distances to healthcare facilities.

For instance, in February 2023, Carestream Health India launched its high-powered Carestream Motion Mobile X-ray system. The system is fully equipped to carry out a full range of general radiography examinations. The new portable imaging system is compact and easy to maneuver into tight spaces. Innovative features such as a tube head and articulating arm for excellent visibility and easy use.

High cost of diagnostic imaging devices

The high cost of diagnostic imaging devices is expected to hamper the market growth, especially in emerging economies and small healthcare facilities. Diagnostic imaging devices such as MRI, CT scanners, and PET scanners require substantial upfront investments, which can be cost highly. This is a significant barrier, particularly for smaller healthcare centers or those in developing regions with limited financial resources.

For instance, according to Block Imaging, Inc., the average cost for a CT scanner varies significantly depending on the model and features, with prices ranging from $80,000 for basic models to up to $300,000 for premium. Typically, buyers can expect to spend between $120,000 and $160,000 for an intermediate-level CT scanner. The average cost of a PET/CT scanner can range from $225,000 for an entry-level scanner to $475,000 for an optimized scanning system. PET/CT scanners can go as high as $750,000 for the latest and greatest.

In addition to high upfront costs, these imaging devices have considerable ongoing maintenance and operational expenses. Regular servicing, software upgrades and repairs are required to keep the equipment functioning efficiently. This adds to the overall burden, especially in developing economies where hospitals and diagnostic centers may already be struggling with tight budgets.

Segment Analysis

The global diagnostic imaging devices market is segmented based on product type, imaging type, portability, application, end-user and region.

Product Type:

The PET/CT scanners segment is expected to dominate the diagnostic imaging devices market share

The PET/CT scanners segment is expected to dominate the global diagnostic imaging devices market. PET/CT scanners combine Positron Emission Tomography (PET) and Computed Tomography (CT), allowing physicians to obtain both functional and anatomical images in a single scan. This fusion of technologies enables on-site technological upgrades, more accurate detection, staging and monitoring of diseases.

For instance, in July 2024, Positron announced that the company is launching its NeuSight PET/CT 3D 64-slice scanner in the U.S. and North American markets. Suitable for both cardiology and oncology imaging, the NeuSight PET/CT scanner offers anatomic and functional imaging for heart, tumor and brain imaging studies.

Continuous advancements in PET/CT scanner technology are making these devices more efficient and accessible. Innovations such as higher-resolution imaging, faster scan times, and improved patient comfort are boosting the adoption of these devices. For instance, in June 2024, Siemens Healthineers unveiled its latest PET/CT scanner, cleared by the U.S. Food and Drug Administration and features a scalable axial field-of-view design that enables on-site technological upgrades without costly room renovations or impeding workflow.

Geographical Analysis

North America is expected to hold a significant position in the diagnostic imaging devices market share

North America is expected to hold the largest market share in the global diagnostic imaging devices market. North America especially the United States is often the first region to adopt new diagnostic imaging technologies, including advanced MRI systems, digital X-rays and AI-powered imaging devices along with the strong presence of major players. The early adoption of innovations allows North America countries to maintain their leadership in the global market.

For instance, in October 2024, FUJIFILM Healthcare Americas Corporation launched the Version 10 (v10) suite of innovations for the ECHELON Synergy 1.5T MRI system. ECHELON Synergy v10 deploys several cutting-edge technologies, including Synergy DLR Clear, Synergy Vision with StillShot and automated scanning process enhancements.

North America, particularly the United States hosts some of the world's largest diagnostic imaging device manufacturers, such as GE Healthcare, Philips Healthcare, Siemens Healthineers and Canon Medical Systems. These companies invest heavily in research and development (R&D) to create next-generation imaging systems that continue to push the boundaries of diagnostic capabilities.

For instance, in December 2024, GE HealthCare unveiled Sonic DL for 3D, a new deep-learning innovation for the company's imaging portfolio. GE HealthCare initially launched Sonic DL in 2023. The company says it provides up to 12 times scan acceleration while maintaining diagnostic quality. This latest enhancement brings the system to 3D volumetric imaging. GE HealthCare wants to broaden the platform's applicability to brain, spine, orthopedic and body exams in addition to cardiac.

Asia-Pacific is growing at the fastest pace in the diagnostic imaging devices market

The Asia-Pacific region is experiencing the fastest growth in the diagnostic imaging devices market. The region is rapidly adopting advanced diagnostic imaging technologies, including AI-powered imaging devices, portable ultrasound machines and hybrid systems (e.g., PET/CT). These innovations are making diagnostic imaging more efficient, affordable and accessible in the region.

For instance, in October 2023, Abbott launched its new vascular imaging platform powered by Ultreon 1.0 Software in India. This first-of-its-kind intra-vascular imaging software combines optical coherence tomography (OCT) with the power of artificial intelligence (AI) providing physicians a comprehensive view of blood flow and blockages within coronary arteries. The innovative imaging software can automatically differentiate between a calcified and non-calcified blockage, detect the severity of calcium-based blockages and measure vessel diameter.

Additionally, in July 2024, Trivitron Healthcare launched its Terrene CT scanner in India. The scanner has received approvals from the Bureau of Indian Standards, Atomic Energy Regulatory Board, and Central Drugs Standard Control Organization, marking a significant milestone in the Indian healthcare industry.

Competitive Landscape

The major global players in the diagnostic imaging devices market include Siemens Healthineers AG, GE HealthCare, Koninklijke Philips N.V., CANON MEDICAL SYSTEMS CORPORATION, FUJIFILM Holdings Corporation, Medtronic plc, Hologic, Inc., Abbott Laboratories, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Carestream Health and among others.

Key Developments

  • In August 2024, Fischer Medical Ventures (FMVL) introduced indigenously developed Computed Tomography (CT) scans. The company developed India's first indigenous Magnetic Resonance Imaging (MRI) system. The company, celebrating its listing on the Bombay Stock Exchange (BSE), announced plans to introduce domestically produced CT scans in collaboration with Edusoft at half the price of current market offerings.
  • In July 2024, LG Electronics (LG) announced that the company expanding its lineup of diagnostic monitors with the new 21HQ613D-B, which was recently cleared by the U.S. Food and Drug Administration for sale in the U.S. Intended for digital mammography and digital breast tomosynthesis, the 21HQ613D-B is a 21.3-inch 5-megapixel (MP) IPS diagnostic monitor designed to deliver high-definition radiological images and maintains consistent image quality through its internal front calibration sensor and calibration software.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews clinical trials, product pipelines, and future advancements in medical devices.
  • Product Performance & Market Positioning: Analyzes product performance and market positioning to refine strategies.
  • Real-World Evidence: Uses patient feedback and data to improve device outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and health system mergers' impact on adoption.
  • Market Updates & Industry Changes: Covers regulatory changes, new policies, and emerging technologies in medical devices.
  • Competitive Strategies: Analyzes competitor strategies, market share, and new entrants in the market.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and access strategies.
  • Market Entry & Expansion: Identifies strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights regions with growth opportunities and investment potential.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and regulatory changes.
  • Post-market Surveillance: Uses post-market data to enhance device safety and access.
  • Cost-Effectiveness & Value-Based Healthcare: Analyzes cost-effectiveness and value-based models in device pricing and adoption.

The global diagnostic imaging devices market report delivers a detailed analysis with 78 key tables, more than 84 visually impactful figures, and 183 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Imaging Type
  • 2.5. Snippet by Portability
  • 2.6. Snippet by Application
  • 2.7. Snippet by End-User
  • 2.8. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Technological Advancements in Diagnostic Imaging Devices
      • 3.1.1.2. Rising Prevalence of Chronic Diseases and Aging Population
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of Diagnostic Imaging Devices
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Diagnostic Imaging Devices Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. PET/CT Scanners*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. C-Arms
  • 5.4. MRI Machines
  • 5.5. Mammography Systems
  • 5.6. Bone Densitometers
  • 5.7. Others

6. Diagnostic Imaging Devices Market, By Imaging Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
    • 6.1.2. Market Attractiveness Index, By Imaging Type
  • 6.2. X-Ray Imaging*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Computed Tomography (CT)
  • 6.4. Magnetic Resonance Imaging (MRI)
  • 6.5. Ultrasound
  • 6.6. Nuclear Imaging
  • 6.7. Mammography
  • 6.8. Others

7. Diagnostic Imaging Devices Market, By Portability

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 7.1.2. Market Attractiveness Index, By Portability
  • 7.2. Portable Devices*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Handheld Devices
  • 7.4. Stationary Equipments

8. Diagnostic Imaging Devices Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Cardiology*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Oncology
  • 8.4. Neurology
  • 8.5. Orthopedics
  • 8.6. Urology
  • 8.7. Gastroenterology
  • 8.8. Others

9. Diagnostic Imaging Devices Market, By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Diagnostic Centers
  • 9.4. Specialty Clinics
  • 9.5. Others

10. Diagnostic Imaging Devices Market, By Regional Market Analysis and Growth Opportunities

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.8.1. U.S.
      • 10.2.8.2. Canada
      • 10.2.8.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.8.1. Germany
      • 10.3.8.2. U.K.
      • 10.3.8.3. France
      • 10.3.8.4. Spain
      • 10.3.8.5. Italy
      • 10.3.8.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.8.1. Brazil
      • 10.4.8.2. Argentina
      • 10.4.8.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.8.1. China
      • 10.5.8.2. India
      • 10.5.8.3. Japan
      • 10.5.8.4. South Korea
      • 10.5.8.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Imaging Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape and Market Positioning

  • 11.1. Competitive Overview and Key Market Players
  • 11.2. Market Share Analysis and Positioning Matrix
  • 11.3. Strategic Partnerships, Mergers & Acquisitions
  • 11.4. Key Developments in Product Portfolios and Innovations
  • 11.5. Company Benchmarking

12. Company Profiles

  • 12.1. Siemens Healthineers AG*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
    • 12.1.5. SWOT Analysis
  • 12.2. GE HealthCare
  • 12.3. Koninklijke Philips N.V.
  • 12.4. CANON MEDICAL SYSTEMS CORPORATION
  • 12.5. FUJIFILM Holdings Corporation
  • 12.6. Medtronic plc
  • 12.7. Hologic, Inc.
  • 12.8. Abbott Laboratories
  • 12.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 12.10. Carestream Health

LIST NOT EXHAUSTIVE

13. Assumption and Research Methodology

  • 13.1. Data Collection Methods
  • 13.2. Data Triangulation
  • 13.3. Forecasting Techniques
  • 13.4. Data Verification and Validation

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us